Literature DB >> 20501016

Optimal surgical technique, use of intra-operative cholangiography (IOC), and management of acute gallbladder disease: the results of a nation-wide survey in the UK and Ireland.

P Sanjay1, C Kulli, F M Polignano, I S Tait.   

Abstract

INTRODUCTION: There is debate on optimal techniques that reduce bile duct injury during laparoscopic cholecystectomy (LC). A national survey of Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS) members was carried out to determine current surgical practice for gallstones, including the use of intra-operative cholangiography (IOC) or critical view of safety to reduce the risk of bile duct injury. SUBJECTS AND METHODS: An anonymous postal survey was sent to all 417 AUGIS members. Data on grade of surgeon, place of work (district general hospital, teaching), subspecialty, number LC per year, use of IOC, critical view of safety, and management of stones detected during surgery were collated.
RESULTS: There was a 36% (152/417) response - 134 (88%) from consultant surgeons (36, HPB; 106,OG; 64, DGH; 88, teaching hospital). Of these, 38% performed > 100 LC per year, 36% 50-100 LC per year, and 22% 25-50 LC per year. IOC was routine for 24%; and selective for 72%. Critical view of Calot's triangle was advocated by 82%. Overall, 55% first clip and divide the cystic artery, whereas 41% first clip and divide the cystic duct. Some 39% recommend IOC and 23% pre-operative MRCP if dilated common bile duct (CBD) is noted on pre-operative ultrasound. When bile duct stones are identified on IOC, 61% perform laparoscopic CBD exploration (LCBDE), 25% advise postoperative ERCP, and 13% perform either LCBDE or ERCP. Overall, 88% (n = 134) recommend index cholecystectomy for acute pathology, and this is more likely in a teaching hospital setting (P = 0.003). Laparoscopic CBD exploration was more likely to be performed in university hospitals (P < 0.05).
CONCLUSIONS: A wide dissection of Calot's triangle to provide a critical view of safety is the technique most commonly recommended by AUGIS surgeons (83%) to minimise risk of bile duct injury, in contrast to 24% that recommend routine IOC. The majority (88%) of AUGIS surgeons advise index admission cholecystectomy for acute gallbladder disease.

Entities:  

Mesh:

Year:  2010        PMID: 20501016      PMCID: PMC3025204          DOI: 10.1308/003588410X12628812458617

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  23 in total

1.  [Calculi of the common bile duct (520 cases under the control of surgical cholangiography)].

Authors:  P L MIRIZZI
Journal:  Mem Acad Chir (Paris)       Date:  1955 Oct 26-Nov 9

2.  Management of acute cholecystitis in UK hospitals: time for a change.

Authors:  I C Cameron; C Chadwick; J Phillips; A G Johnson
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

3.  Intraoperative cholangiography and risk of common bile duct injury during cholecystectomy.

Authors:  David R Flum; E Patchen Dellinger; Allen Cheadle; Leighton Chan; Thomas Koepsell
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

4.  Yield of prospective, noninvasive evaluation of the common bile duct combined with selective ERCP/sphincterotomy in 1390 consecutive laparoscopic cholecystectomy patients.

Authors:  R Rieger; W Wayand
Journal:  Gastrointest Endosc       Date:  1995-07       Impact factor: 9.427

5.  Prospective randomized study of routine intraoperative cholangiography during open cholecystectomy: long-term follow-up and multivariate analysis of predictors of choledocholithiasis.

Authors:  M Hauer-Jensen; R Karesen; K Nygaard; K Solheim; E J Amlie; O Havig; A R Rosseland
Journal:  Surgery       Date:  1993-03       Impact factor: 3.982

Review 6.  An analysis of the problem of biliary injury during laparoscopic cholecystectomy.

Authors:  S M Strasberg; M Hertl; N J Soper
Journal:  J Am Coll Surg       Date:  1995-01       Impact factor: 6.113

7.  Must ERCP Be routinely performed if choledocholithiasis is suspected?

Authors:  C Hoyuela; E Cugat; P Bretcha; P Collera; J Espinós; C Marco
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

8.  A survey of the timing and approach to the surgical management of cholelithiasis in patients with acute biliary pancreatitis and acute cholecystitis in the UK.

Authors:  P S P Senapati; D Bhattarcharya; G Harinath; B J Ammori
Journal:  Ann R Coll Surg Engl       Date:  2003-09       Impact factor: 1.891

9.  Useful predictors of bile duct stones in patients undergoing laparoscopic cholecystectomy. McGill Gallstone Treatment Group.

Authors:  A N Barkun; J S Barkun; G M Fried; G Ghitulescu; O Steinmetz; C Pham; J L Meakins; C A Goresky
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

10.  One thousand laparoscopic cholecystectomies in a single surgical unit using the "critical view of safety" technique.

Authors:  C Avgerinos; D Kelgiorgi; Z Touloumis; L Baltatzi; C Dervenis
Journal:  J Gastrointest Surg       Date:  2008-11-14       Impact factor: 3.452

View more
  11 in total

Review 1.  Meta-analysis of one- vs. two-stage laparoscopic/endoscopic management of common bile duct stones.

Authors:  Nicholas Alexakis; Saxon Connor
Journal:  HPB (Oxford)       Date:  2012-02-03       Impact factor: 3.647

2.  Routine use of simultaneous laparoendoscopic approach in patients with confirmed gallbladder and bile duct stones: fit for laparoscopy fit for "rendezvous".

Authors:  Cinzia Tommasi; Lapo Bencini; Marco Bernini; Riccardo Naspetti; Giulia Cavallina; Roberto Manetti; Luca Talamucci; Marco Farsi
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

3.  Cost analysis of laparoendoscopic rendezvous versus preoperative ERCP and laparoscopic cholecystectomy in the management of cholecystocholedocholithiasis.

Authors:  Aldo Garbarini; Dario Reggio; Simone Arolfo; Marco Bruno; Roberto Passera; Giorgia Catalano; Claudio Barletti; Mauro Salizzoni; Mario Morino; Luca Petruzzelli; Alberto Arezzo
Journal:  Surg Endosc       Date:  2016-12-06       Impact factor: 4.584

4.  Near-infrared cholecysto-cholangiography with indocyanine green may secure cholecystectomy in difficult clinical situations: proof of the concept in a porcine model.

Authors:  Yu-Yin Liu; Seong-Ho Kong; Michele Diana; Andras Lègner; Chun-Chi Wu; Noriaki Kameyama; Bernard Dallemagne; Jacques Marescaux
Journal:  Surg Endosc       Date:  2015-10-28       Impact factor: 4.584

Review 5.  Modern approach to cholecysto-choledocholithiasis.

Authors:  Lapo Bencini; Cinzia Tommasi; Roberto Manetti; Marco Farsi
Journal:  World J Gastrointest Endosc       Date:  2014-02-16

6.  Inpatient magnetic resonance cholangiopancreatography: does it increase the efficiency in emergency hepatopancreaticobiliary surgery services?

Authors:  J A Milburn; J A Bailey; Wk Dunn; I C Cameron; D S Gomez
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

Review 7.  Quality of Life and Medico-Legal Implications Following Iatrogenic Bile Duct Injuries.

Authors:  Deepak Hariharan; Emmanouil Psaltis; John H Scholefield; Dileep N Lobo
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

Review 8.  Population-Based Studies Should not be Used to Justify a Policy of Routine Cholangiography to Prevent Major Bile Duct Injury During Laparoscopic Cholecystectomy.

Authors:  A Peter Wysocki
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

9.  Visibility enhancement of common bile duct for laparoscopic cholecystectomy by vivid fiber-optic indication: a porcine experiment trial.

Authors:  Hsing-Ying Lin; Chen-Han Huang; Shannon Shy; Yu-Chung Chang; Hsiang-Chen Chui; Tsung-Chih Yu; Chih-Han Chang
Journal:  Biomed Opt Express       Date:  2012-07-31       Impact factor: 3.732

10.  Safety measures during cholecystectomy: results of a nationwide survey.

Authors:  K T Buddingh; H S Hofker; H O ten Cate Hoedemaker; G M van Dam; R J Ploeg; V B Nieuwenhuijs
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.